Daniel Passeri MSc., J.D. — Consultant at Curis

Mr. Daniel R. Passeri, also known as Dan, MSc., J.D. has been the Chief Executive Officer and President at Cue Biopharma, Inc. since August 2016 and serves as its Director. Mr. Passeri is a seasoned biotechnology executive with over 20 years of experience managing drug discovery and development programs as well as business development activities on behalf of publicly traded companies, with deep experience in both oncology and strategic partnership generation. has been Consultant of Curis, Inc. since September 14, 2016. Mr. Passeri served as Strategic Advisor of Curis, Inc. since June 3, 2014 until September 14, 2016. Mr. Passeri served as the Chief Executive Officer of Curis, Inc. from September 2001 to June 2, 2014 and served as its President from September 2001 to February 2013. Mr. Passeri served as Senior Vice President, Corporate Development and Strategic Planning of Curis Inc., from November 2000 to September 2001. From March 1997 to November 2000, he was employed by GeneLogic Inc., as Senior Vice President of Corporate Development and Strategic Planning. From February 1995 to March 1997, he was employed by Boehringer Mannheim as Director of Technology Management. He served as Vice Chairman of Curis, Inc. since June 2, 2014 until September 14, 2016. He serves as a Director at Cue Biopharma, Inc. Mr. Passeri served as a Director of Curis, Inc. since September 2001 until September 14, 2016. He is a graduate of the National Law Center at George Washington University, with a J.D., of the Imperial College of Science, Technology and Medicine at the University of London, with an M.Sc. in biotechnology and of Northeastern University, with a B.S in Biology.